Wastewater surveillance for 168 pharmaceuticals and metabolites in a WWTP: Occurrence, temporal variations and feasibility of metabolic biomarkers for intake estimation

Water Analysis: Emerging Contaminants and Current Issues

“…In a wastewater-based epidemiology study including a broad range of pharmaceuticals and metabolites in China, 168 pharmaceuticals were monitored by Duan et al 147 The study highlighted daily consumption pattern variations and proposed a framework for determining whether a parent compound or metabolite can be used for intake rate estimation, highlighting the unreliability of using certain metabolites as biomarkers due to their instability. Pharmaceuticals have been found in significant concentrations in municipal solid waste (MSW) landfill leachates, a source often overlooked for pharmaceuticals in the environment.…”

Comparative study of electro‐Fenton and photoelectro‐Fenton processes using a novel photocatalytic fuel cell electro‐Fenton system with g‐C3N4@N‐TiO2 and Ag/CNT@CF as electrodes

“…In recent years, there has been widespread concern because pharmaceutical and personal care products (PPCPs) have been continuously detected in the effluent of wastewater treatment plants and natural water bodies (Duan et al, 2022; Khan et al, 2022; Sengar & Vijayanandan, 2022). Even though most PPCPs are not refractory organic materials, it remains a challenge to completely remove them and make them environmentally safe (Narayanan et al, 2023; Shi et al, 2022; Singh & Suthar, 2021).…”

Stability and WBE biomarkers possibility of 17 antiviral drugs in sewage and gravity sewers

“…Wastewater-based epidemiology (WBE) is an objective, timely and convenient monitoring tool and is developed to back-estimate the regional consumption of illicit drugs and pharmaceuticals by analyzing human-excreted compounds in municipal wastewater influent ( Daughton, 2001a ; 2001b ; 2018 ). WBE has been successfully used to estimate illicit drug abuse ( Lancaster et al, 2019 ; Thomas et al, 2012 ; Zheng et al, 2021 ), the consumption of alcohol and tobacco ( Reid et al, 2011 ; Wang et al, 2021 ; Zheng et al, 2020 ), the usage of common pharmaceuticals ( Duan et al, 2022 ; Gao et al, 2016 ; Tomsone et al, 2022 ; Xu et al, 2022a ) and the prevalence of hepatitis B ( Hou et al, 2020 ). Currently, WBE is also being developed to apply to monitor SARS-CoV-2 ( Acosta et al, 2022 ; Li et al, 2022 ; Medema et al, 2020 ; Xu et al, 2022b ).…”